C, L., K, D., D, C., AM, M., Z, U., & Jr, H. C. (2020). Challenging the management of drug-resistant tuberculosis - Authors' reply. Lancet (London, England), 395(10226), 783. https://doi.org/10.1016/S0140-6736(20)30055-6
Chicago Style (17th ed.) CitationC, Lange, Dheda K, Chesov D, Mandalakas AM, Udwadia Z, and Horsburgh CR Jr. "Challenging the Management of Drug-resistant Tuberculosis - Authors' Reply." Lancet (London, England) 395, no. 10226 (2020): 783. https://doi.org/10.1016/S0140-6736(20)30055-6.
MLA (9th ed.) CitationC, Lange, et al. "Challenging the Management of Drug-resistant Tuberculosis - Authors' Reply." Lancet (London, England), vol. 395, no. 10226, 2020, p. 783, https://doi.org/10.1016/S0140-6736(20)30055-6.
Warning: These citations may not always be 100% accurate.